Document:

THIS WARRANT AND THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY
STATE, AND MAY NOT BE TRANSFERRED IN VIOLATION OF SUCH ACT, THE RULES AND
REGULATIONS THEREUNDER OR ANY STATE SECURITIES LAWS OR THE PROVISIONS OF THIS
WARRANT.

                     No. of Shares of Common Stock: ________

                                     WARRANT

                           To Purchase Common Stock of

                                 SIRICOMM, INC.

         THIS IS TO CERTIFY THAT Sanders Morris Harris Inc. (the "Holder"), or
his registered assigns, is entitled, at any time from the Warrant Issuance Date
(as hereinafter defined) to the Expiration Date (as hereinafter defined), to
purchase from SIRICOMM, INC., a Delaware corporation (the "Company"),
_________________________________ (______) shares of Common Stock (as
hereinafter defined and subject to adjustment as provided herein), in whole or
in part, including fractional parts, at a purchase price per share equal to
$1.15 subject to any adjustments made to such amount pursuant to Section 4
hereto) on the terms and conditions and pursuant to the provisions hereinafter
set forth.

1.    DEFINITIONS

         As used in this Warrant, the following terms have the respective
meanings set forth below:

         "Additional Shares of Common Stock" shall mean all shares of Common
Stock issued by the Company after the Closing Date, other than Warrant Stock.

         "Book Value" shall mean, in respect of any share of Common Stock on any
date herein specified, the consolidated book value of the Company as of the last
day of any month immediately preceding such date, divided by the number of Fully
Diluted Outstanding shares of Common Stock as determined in accordance with GAAP
(assuming the payment of the exercise prices for such shares) by a firm of
independent certified public accountants of recognized national standing
selected by the Company and reasonably acceptable to the Holder.

         "Business Day" shall mean any day that is not a Saturday or Sunday or a
day on which banks are required or permitted to be closed in the State of New
York.

         "Closing Date" shall mean _____________ ____, 200_, or such other time
as is mutually agreed to by the parties hereto.

         "Commission" shall mean the Securities and Exchange Commission or any
other federal agency then administering the Securities Act and other federal
securities laws.

         "Common Stock" shall mean (except where the context otherwise
indicates) the Common Stock, par value $.001 per share, of the Company as
constituted on the Closing Date, and any capital stock into which such Common
Stock may thereafter be changed, and shall also include (i) capital stock of the
Company of any other class (regardless of how denominated) issued to the holders
of shares of Common Stock upon any reclassification thereof which is also not
preferred as to dividends or assets over any other class of stock of the Company
and which is not subject to redemption and (ii) shares of common stock of any
successor or acquiring corporation received by or distributed to the holders of
Common Stock of the Company in the circumstances contemplated by Section 4.3.

         "Convertible Securities" shall mean evidences of indebtedness, shares
of stock or other securities which are convertible into or exchangeable, with or
without payment of additional consideration in cash or property, for shares of
Common Stock, either immediately or upon the occurrence of a specified date or a
specified event.

         "Current Warrant Price" shall mean $1.15 subject to any adjustments to
such amount made in accordance with Section 4 hereof.

         "Exchange Act" shall mean the Securities Exchange Act of 1934, as
amended, or any successor federal statute, and the rules and regulations of the
Commission thereunder, all as the same shall be in effect from time to time.

         "Exercise Period" shall mean the period during which this Warrant is
exercisable pursuant to Section 2.1.

         "Expiration Date" shall mean the five-year anniversary of the Closing
Date.

         "Fully Diluted Outstanding" shall mean, when used with reference to
Common Stock, at any date as of which the number of shares thereof is to be
determined, all shares of Common Stock Outstanding at such date and all shares
of Common Stock issuable in respect of this Warrant, outstanding on such date,
and other options or warrants to purchase, or securities convertible into,
including without limitation the shares of Common Stock outstanding on such date
which would be deemed outstanding in accordance with GAAP for purposes of
determining book value or net income per share.

         "GAAP" shall mean generally accepted accounting principles in the
United States of America as from time to time in effect.

         "Holder" shall mean the Person in whose name the Warrant or Warrant
Stock set forth herein is registered on the books of the Company maintained for
such purpose.

         "Market Price" per Common Share means the average of the closing bid
prices of the Common Shares as reported on the National Association of
Securities Dealers Automated Quotation System for the National Market,
("NASDAQ") or, if such security is not listed or admitted to trading on the
NASDAQ, on the principal national security exchange or quotation system on which
such security is quoted or listed or admitted to trading, or, if not quoted or
listed or admitted to trading on any national securities exchange or quotation
system, the closing bid price of such security on the over-the-counter market on
the day in question as reported by the National Association of Security Dealers,
Inc., or a similar generally accepted reporting service, as the case may be, for
the five (5) trading days immediately preceding the date of determination.

         "Offering" means the private offering on a best efforts basis of
4,700,000 Units whereby Sanders Morris Harris Inc. acted as placement agent.

         "Other Property" shall have the meaning set forth in Section 4.5.

         "Outstanding" shall mean, when used with reference to Common Stock, at
any date as of which the number of shares thereof is to be determined, all
issued shares of Common Stock, except shares then owned or held by or for the
account of the Company or any subsidiary thereof, and shall include all shares
issuable in respect of outstanding scrip or any certificates representing
fractional interests in shares of Common Stock.

         "Person" shall mean any individual, sole proprietorship, partnership,
joint venture, trust, incorporated organization, association, corporation,
institution, public benefit corporation, entity or government (whether federal,
state, county, city, municipal or otherwise, including, without limitation, any
instrumentality, division, agency, body or department thereof).

         "Restricted Common Stock" shall mean shares of Common Stock which are,
or which upon their issuance on the exercise of this Warrant would be, evidenced
by a certificate bearing the restrictive legend set forth in Section 9.1(a).

         "Securities Act" shall mean the Securities Act of 1933, as amended, or
any successor federal statute, and the rules and regulations of the Commission
thereunder, all as the same shall be in effect at the time.

         "Transfer" shall mean any disposition of any Warrant or Warrant Stock
or of any interest in either thereof, which would constitute a sale thereof
within the meaning of the Securities Act.

         "Transfer Notice" shall have the meaning set forth in Section 9.2.

         "Unit" shall mean a unit issued pursuant to the Offering, each
consisting of one share of Common Stock and one Warrant.

         "Warrant Issuance Date" shall mean the date on which the Warrants are
issued to the Holder.

         "Warrants" shall mean this Warrant and all warrants issued upon
transfer, division or combination of, or in substitution for, any thereof. All
Warrants shall at all times be identical as to terms and conditions and date,
except as to the number of shares of Common Stock for which they may be
exercised.

         "Warrant Price" shall mean an amount equal to (i) the number of shares
of Common Stock being purchased upon exercise of this Warrant pursuant to
Section 2.1, multiplied by (ii) the Current Warrant Price as of the date of such
exercise.

         "Warrant Stock" shall mean the shares of Common Stock purchased by the
holders of the Warrants upon the exercise thereof.

2. EXERCISE OF WARRANT

         2.1. Manner of Exercise. From and after the Warrant Issuance Date and
until 5:00 P.M., New York City time, on the Expiration Date, Holder may exercise
this Warrant, on any Business Day, for all or any part of the number of shares
of Common Stock purchasable hereunder. In order to exercise this Warrant, in
whole or in part, Holder shall:

         (a) deliver to the Company at the office or agency designated by the
Company pursuant to Section 15.2, (i) a written notice of Holder's election to
exercise this Warrant, which notice shall specify the number of shares of Common
Stock to be purchased (a "Notice of Exercise"), (ii) payment by cash, check or
bank draft payable to the Company of the Warrant Price in cash or by wire
transfer or cashier's check drawn on a United States bank for all shares then
being purchased and (iii) this Warrant; or

         (b) In lieu of exercising this Warrant pursuant to clause (a) above,
the Holder may elect to receive, without the payment by the Holder of any
additional consideration, Warrant Stock equal to the value of this Warrant (or
the portion thereof being canceled) by surrender of this Warrant at the
principal office of the Company together with an executed Notice of Exercise, in
which event the Company shall issue to the holder hereof a number of Warrant
Stock computed using the following formula:

                                          Y (A - B)
                                          ---------
                                   X =        A

         Where:      X =    The number of shares of Warrant Stock to be
                            issued to the Holder pursuant to this net exercise;

                     Y =    The number of shares of Warrant Stock in
                            respect of which the net exercise election
                            under this Section 4(b) is made;

                     A =    The fair market value of one share of
                            Warrant Stock at the time the net exercise
                            election is made; and

                     B =    The Exercise Price.

For purposes of this provision, the fair market value of a share of Warrant
Stock as of a particular date shall be the closing sale price of the Common
Stock on the trading date immediately prior to the date of exercise as quoted on
the OTC Bulletin Board or any United States automated quotation system or
national securities exchange on which the Common Stock are then quoted or
traded, as applicable; provided, however, that if the Common Stock is not then
so quoted or traded, the fair market value of the Warrant Stock shall be
determined by the Board of Directors of the Company in its reasonable good faith
discretion.

         Such Notice of Exercise shall be substantially in the form of the
subscription form appearing at the end of this Warrant as Exhibit 1, duly
executed by Holder or its agent or attorney. Upon receipt of the items referred
to in clauses (a) or (b) above, the Company shall, as promptly as practicable,
and in any event within five (5) Business Days thereafter, execute or cause to
be executed and deliver or cause to be delivered to Holder a certificate or
certificates representing the aggregate number of full shares of Common Stock
issuable upon such exercise, together with cash in lieu of any fraction of a
share, as hereinafter provided. The stock certificate or certificates so
delivered shall be, to the extent possible, in such denomination or
denominations as Holder shall request in the notice and shall be registered in
the name of Holder or, subject to Section 9, such other name as shall be
designated in the notice. This Warrant shall be deemed to have been exercised
and such certificate or certificates shall be deemed to have been issued, and
Holder or any other Person so designated to be named therein shall be deemed to
have become a holder of record of such shares for all purposes, as of the date
the Warrant has been exercised by payment to the Company of the Warrant Price.
If this Warrant shall have been exercised in part, the Company shall, at the
time of delivery of the certificate or certificates representing Warrant Stock,
deliver to Holder a new Warrant evidencing the rights of Holder to purchase the
unpurchased shares of Common Stock called for by this Warrant, which new Warrant
shall in all other respects be identical with this Warrant.

         The Holder shall be entitled to exercise the Warrant notwithstanding
the commencement of any case under 11 U.S.C. ss. 101 et seq. (the "Bankruptcy
Code"). In the event the Company is a debtor under the Bankruptcy Code, the
Company hereby waives to the fullest extent permitted any rights to relief it
may have under 11 U.S.C. ss. 362 in respect of the Holder's exercise right. The
Company hereby waives to the fullest extent permitted any rights to relief it
may have under 11 U.S.C. ss. 362 in respect of the exercise of the Warrant. The
Company agrees, without cost or expense to the Holder, to take or consent to any
and all action necessary to effectuate relief under 11 U.S.C. ss. 362. 2.2.
Payment of Taxes and Charges. All shares of Common Stock issuable upon the
exercise of this Warrant pursuant to the terms hereof shall be validly issued,
fully paid and nonassessable, and without any preemptive rights. The Company
shall pay all expenses in connection with, and all taxes and other governmental
charges that may be imposed with respect to, the issue or delivery thereof.

         2.3. Fractional Shares. The Company shall not be required to issue a
fractional share of Common Stock upon exercise of any Warrant. As to any
fraction of a share which Holder would otherwise be entitled to purchase upon
such exercise, the Company shall pay a cash adjustment in respect of such final
fraction in an amount equal to the same fraction of the Market Price per share
of Common Stock on the relevant exercise date.

         2.4. Continued Validity. A holder of shares of Common Stock issued upon
the exercise of this Warrant, in whole or in part (other than a holder who
acquires such shares after the same have been publicly sold pursuant to a
Registration Statement under the Securities Act or sold pursuant to Rule 144
thereunder), shall continue to be entitled with respect to such shares to all
rights to which it would have been entitled as Holder under Sections 9, 10 and
14 of this Warrant. The Company will, at the time of exercise of this Warrant,
in whole or in part, upon the request of Holder, acknowledge in writing, in form
reasonably satisfactory to Holder, its continuing obligation to afford Holder
all such rights; provided, however, that if Holder shall fail to make any such
request, such failure shall not affect the continuing obligation of the Company
to afford to Holder all such rights.

3. TRANSFER, DIVISION AND COMBINATION

         3.1. Transfer. Subject to compliance with Section 9, transfer of this
Warrant and all rights hereunder, in whole or in part, shall be registered on
the books of the Company to be maintained for such purpose, upon surrender of
this Warrant at the principal office of the Company referred to in Section 2.1
or the office or agency designated by the Company pursuant to Section 13,
together with a written assignment of this Warrant substantially in the form of
Exhibit 2 hereto duly executed by Holder or its agent or attorney. Upon such
surrender, the Company shall, subject to Section 9, execute and deliver a new
Warrant or Warrants in the name of the assignee or assignees and in the
denomination specified in such instrument of assignment, and shall issue to the
assignor a new Warrant evidencing the portion of this Warrant not so assigned,
and this Warrant shall promptly be cancelled. A Warrant, if properly assigned in
compliance with Section 9, may be exercised by a new Holder for the purchase of
shares of Common Stock without having a new Warrant issued.

         3.2. Division and Combination. Subject to Section 9, this Warrant may
be divided or combined with other Warrants upon presentation hereof at the
aforesaid office or agency of the Company, together with a written notice
specifying the names and denominations in which new Warrants are to be issued,
signed by Holder or its agent or attorney. Subject to compliance with Section
3.1 and with Section 9, as to any transfer which may be involved in such
division or combination, the Company shall execute and deliver a new Warrant or
Warrants in exchange for the Warrant or Warrants to be divided or combined in
accordance with such notice.

         3.3. Expenses. The Company shall prepare, issue and deliver at its own
expense the new Warrant or Warrants under this Section 3.

         3.4. Maintenance of Books. The Company agrees to maintain, at its
aforesaid office or agency, books for the registration and the registration of
transfer of the Warrants.

4. ADJUSTMENTS

                  The number of shares of Common Stock for which this Warrant is
exercisable, or the price at which such shares may be purchased upon exercise of
this Warrant, shall be subject to adjustment from time to time as set forth in
this Section 4. The Company shall give Holder notice of any event described
below which requires an adjustment pursuant to this Section 4 at the time of
such event.

         4.1. Stock Dividends, Subdivisions and Combinations. If at any time the
Company shall:

         (a) take a record of the holders of its Common Stock for the purpose of
entitling them to receive a dividend payable in, or other distribution of,
Additional Shares of Common Stock,

         (b) subdivide its outstanding shares of Common Stock into a larger
number of shares of Common Stock, or

         (c) combine its outstanding shares of Common Stock into a smaller
number of shares of Common Stock,

         then (i) the number of shares of Common Stock for which this Warrant is
exercisable immediately after the occurrence of any such event shall be adjusted
to equal the number of shares of Common Stock which a record holder of the same
number of shares of Common Stock for which this Warrant is exercisable
immediately prior to the occurrence of such event would own or be entitled to
receive after the happening of such event, and (ii) the Current Warrant Price
shall be adjusted to equal (A) the Current Warrant Price multiplied by the
number of shares of Common Stock for which this Warrant is exercisable
immediately prior to the adjustment divided by (B) the number of shares for
which this Warrant is exercisable immediately after such adjustment.

         4.2. Other Provisions Applicable to Adjustments under this Section. The
following provisions shall be applicable to the making of adjustments of the
number of shares of Common Stock for which this Warrant is exercisable and the
Current Warrant Price provided for in this Section 4:

         (a) When Adjustments to Be Made. The adjustments required by this
Section 4 shall be made whenever and as often as any specified event requiring
an adjustment shall occur. For the purpose of any adjustment, any specified
event shall be deemed to have occurred at the close of business on the date of
its occurrence.

         (b) Fractional Interests. In computing adjustments under this Section
4, fractional interests in Common Stock shall be taken into account to the
nearest 1/10th of a share.

         (c) When Adjustment Not Required. If the Company shall take a record of
the holders of its Common Stock for the purpose of entitling them to receive a
dividend or distribution or subscription or purchase rights and shall,
thereafter and before the distribution to stockholders thereof, legally abandon
its plan to pay or deliver such dividend, distribution, subscription or purchase
rights, then thereafter no adjustment shall be required by reason of the taking
of such record and any such adjustment previously made in respect thereof shall
be rescinded and annulled.

         (d) Challenge to Good Faith Determination. Whenever the Board of
Directors of the Company shall be required to make a determination in good faith
of the fair value of any item under this Section 4, such determination may be
challenged in good faith by the Holder, and any dispute shall be resolved by an
investment banking firm of recognized national standing selected by the Holder
and reasonably acceptable to the Company.

         (e) Proceeding Prior to Any Action Requiring Adjustment. As a condition
precedent to the taking of any action which would require an adjustment pursuant
to this Section 4, the Company shall take any action which may be necessary,
including obtaining regulatory approvals or exemptions, in order that the
Company may thereafter validly and legally issue as fully paid and nonassessable
all shares of Common Stock which the Holder is entitled to receive upon exercise
hereof.

         4.3. Reorganization, Reclassification, Merger, Consolidation or
Disposition of Assets. In case the Company shall reorganize its capital,
reclassify its capital stock, consolidate or merge with or into another
corporation (where the Company is not the surviving corporation or where there
is a change in or distribution with respect to the Common Stock of the Company),
or sell, transfer or otherwise dispose of all or substantially all its property,
assets or business to another corporation and, pursuant to the terms of such
reorganization, reclassification, merger, consolidation or disposition of
assets, shares of common stock of the successor or acquiring corporation, or any
cash, shares of stock or other securities or property of any nature whatsoever
(including warrants or other subscription or purchase rights) in addition to or
in lieu of common stock of the successor or acquiring corporation ("Other
Property"), are to be received by or distributed to the holders of Common Stock
of the Company, then Holder shall have the right thereafter to receive, upon
exercise of the Warrant, the number of shares of common stock of the successor
or acquiring corporation or of the Company, if it is the surviving corporation,
and Other Property receivable upon or as a result of such reorganization,
reclassification, merger, consolidation or disposition of assets by a holder of
the number of shares of Common Stock for which this Warrant is exercisable
immediately prior to such event. In case of any such reorganization,
reclassification, merger, consolidation or disposition of assets, the successor
or acquiring corporation (if other than the Company) shall expressly assume the
due and punctual observance and performance of each and every covenant and
condition of this Warrant to be performed and observed by the Company and all
the obligations and liabilities hereunder, subject to such modifications as may
be deemed appropriate, subject to the Holder's consent, in order to provide for
adjustments of shares of Common Stock for which this Warrant is exercisable
which shall be as nearly equivalent as practicable to the adjustments provided
for in this Section 4. For purposes of this Section 4.3, "common stock of the
successor or acquiring corporation" shall include stock of such corporation of
any class which is not preferred as to dividends or assets over any other class
of stock of such corporation and which is not subject to redemption and shall
also include any evidences of indebtedness, shares of stock or other securities
which are convertible into or exchangeable for any such stock, either
immediately or upon the arrival of a specified date or the happening of a
specified event and any warrants or other rights to subscribe for or purchase
any such stock. The foregoing provisions of this Section 4.3 shall similarly
apply to successive reorganizations, reclassifications, mergers, consolidations
or disposition of assets.

         4.4. Other Action Affecting Common Stock. In case at any time or from
time to time the Company shall take any action in respect of its Common Stock,
other than any action taken in the ordinary course of the Company's business or
any action described in this Section 4, which would have a material adverse
effect upon the rights of the Holder, the number of shares of Common Stock
and/or the purchase price thereof shall be adjusted in such manner as may be
equitable in the circumstances, as determined in good faith by an investment
bank selected by Holder.

         4.5. Certain Limitations. Notwithstanding anything herein to the
contrary, the Company agrees not to enter into any transaction which, by reason
of any adjustment hereunder, would cause the Current Warrant Price to be less
than the par value per share of Common Stock.

         4.6. No Stockholder Rights. Prior to exercise of this Warrant, the
Holder shall not be entitled to any rights of a stockholder with respect to the
Warrant Stock, including (without limitation) the right to vote such Warrant
Stock, receive dividends or other distributions thereon, exercise preemptive
rights or be notified of stockholder meetings, and such Holder shall not be
entitled to any notice or other communication concerning the business or affairs
of the Company. However, nothing in this Section 4.6 shall limit the right of
the Holder to be provided the notices required under this Warrant.

5. NOTICES TO HOLDER

         5.1. Notice of Adjustments. Whenever the number of shares of Common
Stock for which this Warrant is exercisable, or whenever the price at which a
share of such Common Stock may be purchased upon exercise of the Warrants, shall
be adjusted pursuant to Section 4, the Company shall forthwith prepare a
certificate to be executed by an executive officer of the Company setting forth,
in reasonable detail, the event requiring the adjustment and the method by which
such adjustment was calculated, specifying the number of shares of Common Stock
for which this Warrant is exercisable and describing the number and kind of any
other shares of stock or Other Property for which this Warrant is exercisable,
and any change in the purchase price or prices thereof, after giving effect to
such adjustment or change. The Company shall promptly cause a signed copy of
such certificate to be delivered to the Holder in accordance with Section 15.2.
The Company shall keep at its office or agency designated pursuant to Section 13
copies of all such certificates and cause the same to be available for
inspection at said office during normal business hours by the Holder, its
representatives, or any prospective purchaser of a Warrant designated by the
Holder.

         5.2. Notice of Corporate Action. If at any time

         (a) the Company shall take a record of the holders of its Common Stock
for the purpose of entitling them to receive a dividend or other distribution
(whether in cash, or any right to subscribe for or purchase any evidences of its
indebtedness, any shares of stock of any class or any other securities or
property of any nature whatsoever, or to receive any warrants or other rights
(including, without limitation, rights to subscribe for or purchase any
evidences of its indebtedness, any shares of its stock or any other securities
or property of any nature whatsoever), or

         (b) there shall be any capital reorganization of the Company, any
reclassification or recapitalization of the capital stock of the Company or any
consolidation or merger of the Company with, or any sale, transfer or other
disposition of all or substantially all the property, assets or business of the
Company to, another corporation, or

         (c) there shall be a voluntary or involuntary dissolution, liquidation
or winding up of the Company;

then, in any one or more of such cases, the Company shall give to Holder (i) at
least thirty (30) Business Days' prior written notice of the date on which a
record date shall be selected for such dividend, distribution or right or for
determining rights to vote in respect of any such reorganization,
reclassification, merger, consolidation, sale, transfer, disposition,
dissolution, liquidation or winding up, and (ii) in the case of any such
reorganization, reclassification, merger, consolidation, sale, transfer,
disposition, dissolution, liquidation or winding up, at least thirty (30)
Business Days' prior written notice of the date when the same shall take place.
Such notice in accordance with the foregoing clause also shall specify (i) the
date on which any such record is to be taken for the purpose of such dividend,
distribution or right, the date on which the holders of Common Stock shall be
entitled to any such dividend, distribution or right, and the amount and
character thereof, and (ii) the date on which any such reorganization,
reclassification, merger, consolidation, sale, transfer, disposition,
dissolution, liquidation or winding up is to take place and the time, if any
such time is to be fixed, as of which the holders of Common Stock shall be
entitled to exchange their shares of Common Stock for securities or other
property deliverable upon such reorganization, reclassification, merger,
consolidation, sale, transfer, disposition, dissolution, liquidation or winding
up. Each such written notice shall be sufficiently given if addressed to Holder
at the last address of Holder appearing on the books of the Company and
delivered in accordance with Section 15.2.

         A reclassification of the Common Stock (other than a change in par
value, or from par value to no par value or from no par value to par value) into
shares of Common Stock and shares of any other class of stock shall be deemed a
distribution by the Company to the holders of its Common Stock of such shares of
such other class of stock within the meaning of this Section and, if the
outstanding shares of Common Stock shall be changed into a larger or smaller
number of shares of Common Stock as a part of such reclassification, such change
shall be deemed a subdivision or combination, as the case may be, of the
outstanding shares of Common Stock within the meaning of Section 4.1.

6. NO IMPAIRMENT

         The Company shall not by any action, including, without limitation,
amending its certificate of incorporation or through any reorganization,
transfer of assets, consolidation, merger, dissolution, issue or sale of
securities or any other voluntary action, avoid or seek to avoid the observance
or performance of any of the terms of this Warrant, but will at all times in
good faith assist in the carrying out of all such terms and in the taking of all
such actions as may be necessary or appropriate to protect the rights of Holder
against impairment. Without limiting the generality of the foregoing, the
Company will (a) not increase the par value of any shares of Common Stock
receivable upon the exercise of this Warrant above the amount payable therefor
upon such exercise immediately prior to such increase in par value, (b) take all
such action as may be necessary or appropriate in order that the Company may
validly and legally issue fully paid and nonassessable shares of Common Stock
upon the exercise of this Warrant, and (c) use its best efforts to obtain all
such authorizations, exemptions or consents from any public regulatory body
having jurisdiction thereof as may be necessary to enable the Company to perform
its obligations under this Warrant.

         Upon the request of Holder, the Company will at any time during the
period this Warrant is outstanding acknowledge in writing, in form reasonably
satisfactory to Holder, the continuing validity of this Warrant and the
obligations of the Company hereunder.

7. RESERVATION AND AUTHORIZATION OF COMMON STOCK

         From and after the Closing Date, the Company shall at all times reserve
and keep available for issue upon the exercise of Warrants such number of its
authorized but unissued shares of Common Stock as will be sufficient to permit
the exercise in full of all outstanding Warrants. All shares of Common Stock
which shall be so issuable, when issued upon exercise of any Warrant and payment
therefor in accordance with the terms of such Warrant, shall be duly and validly
issued and fully paid and nonassessable, and not subject to preemptive rights.

         Before taking any action which would cause an adjustment reducing the
Current Warrant Price below the then par value, if any, of the shares of Common
Stock issuable upon exercise of the Warrants, the Company shall take any
corporate action which may be necessary in order that the Company may validly
and legally issue fully paid and non-assessable shares of such Common Stock at
such adjusted Current Warrant Price.

         Before taking any action which would result in an adjustment in the
number of shares of Common Stock for which this Warrant is exercisable or in the
Current Warrant Price, the Company shall obtain all such authorizations or
exemptions thereof, or consents thereto, as may be necessary from any public
regulatory body or bodies having jurisdiction thereof.

8. TAKING OF RECORD; STOCK AND WARRANT TRANSFER BOOKS

         In the case of all dividends or other distributions by the Company to
the holders of its Common Stock with respect to which any provision of Section 4
refers to the taking of a record of such holders, the Company will in each such
case take such a record as of the close of business on a Business Day. The
Company will not at any time close its stock transfer books or Warrant transfer
books so as to result in preventing or delaying the exercise or transfer of any
Warrant.

9. RESTRICTIONS ON TRANSFERABILITY

         The Warrants and the Warrant Stock shall not be transferred,
hypothecated or assigned before satisfaction of the conditions specified in this
Section 9, which conditions are intended to ensure compliance with the
provisions of the Securities Act with respect to the Transfer of any Warrant or
any Warrant Stock. Holder, by acceptance of this Warrant, agrees to be bound by
the provisions of this Section 9.

         9.1. Restrictive Legend. The Holder by accepting this Warrant and any
Warrant Stock agrees that this Warrant and the Warrant Stock issuable upon
exercise hereof may not be assigned or otherwise transferred unless and until
(i) the Company has received an opinion of counsel for the Holder that such
securities may be sold pursuant to an exemption from registration under the
Securities Act or (ii) a registration statement relating to such securities has
been filed by the Company and declared effective by the Commission.

         (a) Each certificate for Warrant Stock issuable hereunder shall bear a
legend substantially worded as follows unless such securities have been sold
pursuant to an effective registration statement under the Securities Act:

                  "The securities represented by this certificate have not been
         registered under the Securities Act of 1933, as amended (the "Act") or
         any state securities laws. The securities may not be offered for sale,
         sold, assigned, offered, transferred or otherwise distributed for value
         except (i) pursuant to an effective registration statement under the
         Act or any state securities laws or (ii) pursuant to an exemption from
         registration or prospectus delivery requirements under the Act or any
         state securities laws in respect of which the Company has received an
         opinion of counsel satisfactory to the Company to such effect. Copies
         of the agreement covering both the purchase of the securities and
         restricting their transfer may be obtained at no cost by written
         request made by the holder of record of this certificate to the
         Secretary of the Company at the principal executive offices of the
         Company."

         (b) Except as otherwise provided in this Section 9, the Warrant shall
be stamped or otherwise imprinted with a legend in substantially the following
form:

                  "This Warrant and the securities represented hereby have not
         been registered under the Securities Act of 1933, as amended, or any
         state securities laws and may not be transferred in violation of such
         Act, the rules and regulations thereunder or any state securities laws
         or the provisions of this Warrant."

         9.2. Notice of Proposed Transfers. Prior to any Transfer or attempted
Transfer of any Warrants or any shares of Restricted Common Stock, the Holder
shall give five (5) days' prior written notice (a "Transfer Notice") to the
Company of Holder's intention to effect such Transfer, describing the manner and
circumstances of the proposed Transfer, and obtain from counsel to Holder an
opinion that the proposed Transfer of such Warrants or such Restricted Common
Stock may be effected without registration under the Securities Act or state
securities laws. After the Company's receipt of the Transfer Notice and opinion,
such Holder shall thereupon be entitled to Transfer such Warrants or such
Restricted Common Stock, in accordance with the terms of the Transfer Notice.
Each certificate, if any, evidencing such shares of Restricted Common Stock
issued upon such Transfer and the Warrant issued upon such Transfer shall bear
the restrictive legends set forth in Section 9.1, unless in the opinion of such
counsel such legend is not required in order to ensure compliance with the
Securities Act.

         9.3. Termination of Restrictions. Notwithstanding the foregoing
provisions of Section 9, the restrictions imposed by this Section upon the
transferability of the Warrants, the Warrant Stock and the Restricted Common
Stock (or Common Stock issuable upon the exercise of the Warrants) and the
legend requirements of Section 9.1 shall terminate as to any particular Warrant
or share of Warrant Stock or Restricted Common Stock (or Common Stock issuable
upon the exercise of the Warrants) (i) when and so long as such security shall
have been effectively registered under the Securities Act and applicable state
securities laws and disposed of pursuant thereto or (ii) when the Company shall
have received an opinion of counsel that such shares may be transferred without
registration thereof under the Securities Act and applicable state securities
laws. Whenever the restrictions imposed by Section 9 shall terminate as to this
Warrant, as hereinabove provided, the Holder hereof shall be entitled to receive
from the Company upon written request of the Holder, at the expense of the
Company, a new Warrant bearing the following legend in place of the restrictive
legend set forth hereon:

                  "THE RESTRICTIONS ON TRANSFERABILITY OF THE WITHIN WARRANT
         CONTAINED IN SECTION 9 HEREOF TERMINATED ON ________, 20__, AND ARE OF
         NO FURTHER FORCE AND EFFECT."

All Warrants issued upon registration of transfer, division or combination of,
or in substitution for, any Warrant or Warrants entitled to bear such legend
shall have a similar legend endorsed thereon. Whenever the restrictions imposed
by this Section shall terminate as to any share of Restricted Common Stock, as
hereinabove provided, the holder thereof shall be entitled to receive from the
Company, at the Company's expense, a new certificate representing such Common
Stock not bearing the restrictive legends set forth in Section 9.1.

         9.4. Listing on Securities Exchange. If the Company shall list any
shares of Common Stock on any securities exchange, it will, at its expense, list
thereon, maintain and, when necessary, increase such listing of, all shares of
Common Stock issued or, to the extent permissible under the applicable
securities exchange rules, issuable upon the exercise of this Warrant so long as
any shares of Common Stock shall be so listed during the Exercise Period.

10. REGISTRATION RIGHTS

         The Holder of this Warrant is entitled to have the shares of Common
Stock purchased in the Offering and the Warrant Stock issuable upon exercise of
this Warrant registered for resale under the Securities Act, pursuant to and in
accordance with the Registration Rights Agreement dated as of the date hereof by
and between the Holder and the Company.

11. SUPPLYING INFORMATION

         The Company shall cooperate with Holder in supplying such information
as may be reasonably necessary for Holder to complete and file any information
reporting forms presently or hereafter required by the Commission as a condition
to the availability of an exemption from the Securities Act for the sale of any
Warrant or Restricted Common Stock.

12.   LOSS OR MUTILATION

         Upon receipt by the Company from Holder of evidence reasonably
satisfactory to it of the ownership of and the loss, theft, destruction or
mutilation of this Warrant and indemnity reasonably satisfactory to it (it being
understood that the written agreement of the Holder shall be sufficient
indemnity), and in case of mutilation upon surrender and cancellation hereof,
the Company will execute and deliver in lieu hereof a new Warrant of like tenor
to Holder; provided, in the case of mutilation, no indemnity shall be required
if this Warrant in identifiable form is surrendered to the Company for
cancellation.

13. OFFICE OF THE COMPANY

         As long as any of the Warrants remain outstanding, the Company shall
maintain an office or agency (which may be the principal executive offices of
the Company) where the Warrants may be presented for exercise, registration of
transfer, division or combination as provided in this Warrant, such office to be
initially located at 2900 Davis Boulevard, Joplin, Missouri 64804, provided,
however, that the Company shall provide prior written notice to Holder of a
change in address no less than thirty (30) days prior to such change.

14. LIMITATION OF LIABILITY

         No provision hereof, in the absence of affirmative action by Holder to
purchase shares of Common Stock, and no enumeration herein of the rights or
privileges of Holder hereof, shall give rise to any liability of Holder for the
purchase price of any Common Stock or as a stockholder of the Company, whether
such liability is asserted by the Company or by creditors of the Company.

15. MISCELLANEOUS

         15.1. Nonwaiver and Expenses. No course of dealing or any delay or
failure to exercise any right hereunder on the part of Holder shall operate as a
waiver of such right or otherwise prejudice Holder's rights, powers or remedies,
notwithstanding all rights hereunder terminate on the Expiration Date. If the
Company fails to make, when due, any payments provided for hereunder, or fails
to comply with any other provision of this Warrant, the Company shall pay to
Holder such amounts as shall be sufficient to cover any direct and indirect
losses, damages, costs and expenses including, but not limited to, reasonable
attorneys' fees, including those of appellate proceedings, incurred by Holder in
collecting any amounts due pursuant hereto or in otherwise enforcing any of its
rights, powers or remedies hereunder.

         15.2. Notice Generally. Except as may be otherwise provided herein, any
notice or other communication or delivery required or permitted hereunder shall
be in writing and shall be delivered personally or sent by certified mail,
postage prepaid, or by a nationally recognized overnight courier service, and
shall be deemed given when so delivered personally or by overnight courier
service, or, if mailed, three (3) days after the date of deposit in the United
States mails, as follows:

(a)   if to the Company, to:    SiriCOMM, Inc.
                                2900 Davis Boulevard
                                Joplin, Missouri  64804
                                Attention:  Henry Hoffman
                                Phone:    (417) 626-9971
                                Fax:      (417) 782-0475

      with a copy to:           Sommer & Schneider LLP
                                595 Stewart Avenue, Suite 710
                                Garden City, NY  11530
                                Attention:  Joel C. Schneider, Esq.
                                Phone: (516) 228-8181
                                Fax: (516) 228-8211

 (b)  if to the Holder to:      Sanders Morris Harris Inc.
                                527 Madison Avenue, 7th Floor
                                New York, New York 10022
                                Attention:  Stephen Bonebrake, Managing Director
                                Phone:  (212) 419-3986
                                Fax:  (212) 419-3956

         The Company or the Holder may change the foregoing address by notice
given pursuant to this Section 15.2.

         15.3. Successors and Assigns. Subject to the provisions of Sections 3.1
and 9, this Warrant and the rights evidenced hereby shall inure to the benefit
of and be binding upon the successors of the Company and the successors and
assigns of Holder. The provisions of this Warrant are intended to be for the
benefit of all Holders from time to time of this Warrant and, with respect to
Section 9 hereof, holders of Warrant Stock, and shall be enforceable by any such
Holder or holder of Warrant Stock.

         15.4. Amendment. This Warrant and all other Warrants may be modified or
amended or the provisions hereof waived only with the prior written consent of
the Company and the Holder.

         15.5. Severability. Wherever possible, each provision of this Warrant
shall be interpreted in such manner as to be effective and valid under
applicable law, but if any provision of this Warrant shall be prohibited by or
invalid under applicable law, such provision shall be ineffective to the extent
of such prohibition or invalidity, without invalidating the remainder of such
provision or the remaining provisions of this Warrant.

         15.6. Headings. The headings used in this Warrant are for the
convenience of reference only and shall not, for any purpose, be deemed a part
of this Warrant.

         15.7. Governing Law. This Warrant shall be governed by the laws of the
state of Delaware, without regard to the choice or conflict of laws principles
thereof.

                            [SIGNATURE PAGE FOLLOWS]

<PAGE>

         IN WITNESS WHEREOF, the Company has caused this Warrant to be duly
executed and its corporate seal to be impressed hereon and attested by its
Secretary or a Company employee.

Dated:  ________________, 200__

                                                SIRICOMM, INC.

[CORPORATE SEAL]

                                                By:____________________________
                                                   Henry P. Hoffman, President
Attest:

By:_____________________________
   Jackie Seneker
   Director of Support Services

ACKNOWLEDGED AND ACCEPTED:

SANDERS MORRIS HARRIS INC.

By:________________________________
Name:
Title:

<PAGE>

                                    EXHIBIT 1

                                SUBSCRIPTION FORM

                 [To be executed only upon exercise of Warrant]

The undersigned registered owner of this Warrant irrevocably exercises this
Warrant for the purchase of ______ Shares of Common Stock of SiriCOMM, Inc., and
herewith makes payment therefor in cash or by check or bank draft made payable
to the Company, all at the price and on the terms and conditions specified in
this Warrant and requests that certificates for the shares of Common Stock
hereby purchased (and any securities or other property issuable upon such
exercise) be issued in the name of and delivered to _____________ whose address
is _________________ and, if such shares of Common Stock shall not include all
of the shares of Common Stock issuable as provided in this Warrant, that a new
Warrant of like tenor and date for the balance of the shares of Common Stock
issuable hereunder be delivered to the undersigned.

                                            ----------------------------------
                                            (Name of Registered Owner)

                                            ----------------------------------
                                            (Signature of Registered Owner)

                                            ----------------------------------
                                            (Street Address)

                                            ----------------------------------
                                            (City) (State) (Zip Code)

         NOTICE: The signature on this subscription must correspond with the
name as written upon the face of the within Warrant in every particular, without
alteration or enlargement or any change whatsoever.

<PAGE>

                                    EXHIBIT 2

                                 ASSIGNMENT FORM

         FOR VALUE RECEIVED the undersigned registered owner of this Warrant
hereby sells, assigns and transfers unto the Assignee named below all of the
rights of the undersigned under this Warrant, with respect to the number of
shares of Common Stock set forth below:

    ____________________________                _____________________________
    Name and Address of Assignee                No. of Shares of Common Stock

and does hereby irrevocably constitute and appoint ________________________
attorney-in-fact to register such transfer on the books of SiriCOMM, Inc.
maintained for the purpose, with full power of substitution in the premises.

         Dated:__________________            Print Name:________________________

                                             Signature:_________________________

                                             Witness:___________________________

         NOTICE: The signature on this assignment must correspond with the name
as written upon the face of the within Warrant in every particular, without
alteration or enlargement or any change whatsoever.PLACEMENT AGENT AGREEMENT

                                December 12, 2005

Sanders Morris Harris Inc.
527 Madison Avenue, 7th Floor
New York, New York 10022

Dear Sirs:

         1. Introductory. SiriCOMM, Inc., a Delaware corporation (the
"Company"), proposes to sell up to 4,700,000 units (the "Units"), each Unit
consisting of (i) one share of common stock of the Company, $0.001 par value per
share (the "Common Stock") and (ii) redeemable Common Stock purchase warrants
(the "Warrants"), each entitling the holder thereof to purchase one share of
Common Stock at $1.50 per share. The purchase price of the Units shall be $1.15
per Unit (the "Offering Price"). The securities comprising the Units shall at
times be referred to as the "Securities" herein.

         2. Representations and Warranties of the Company. The Company
represents, warrants, and agrees that:

                  (i) The representations and warranties of the Company set
         forth in Section 3 of each of the Subscription Agreements (as defined
         below) are true and correct.

                  (ii) The Company is a corporation duly organized, validly
         existing, and in good standing under the laws of the State of Delaware,
         is duly qualified to do business as a foreign corporation and in good
         standing in the State of Missouri, and has all requisite right, power,
         and authority to own or lease its properties, to conduct its business
         as described in the Exchange Act Documents (as defined in the
         Subscription Agreements), and to execute, deliver, and perform this
         Agreement, the Subscription Agreements between the Company and the
         purchasers of the Units in the form attached as Exhibit A hereto (the
         "Subscription Agreements"), the Registration Rights Agreement in the
         form attached as Exhibit B hereto (the "Registration Rights
         Agreement"), the Escrow Agreement among the Company, you, and Sterling
         Bank (the "Escrow Agent") in the form attached as Exhibit C hereto (the
         "Escrow Agreement" and together with the Subscription Agreements and
         the Registration Rights Agreement, the "Related Agreements"), to issue
         and sell the Units, and to carry out the provisions of this Agreement
         and the Related Agreements and to carry on its business as presently
         conducted. The Company is duly qualified to do business and in good
         standing as a foreign corporation in all other jurisdictions in which
         its ownership or leasing of properties, or the conduct of its business
         requires or may require such qualification except where the failure to
         be so qualified would not have a Material Adverse Effect (as defined in
         the Subscription Agreements). The Company has complied in all material
         respects with all material laws, rules, regulations, applicable to the
         Company's business, operations, properties, assets, products, and
         services, and the Company is in possession of and operating in
         compliance with all material permits, licenses, and other
         authorization, required to conduct its business as currently conducted.

                  (iii) All action required to be taken by the Company necessary
         for the authorization of this Agreement and the Related Agreements, the
         performance of all obligations of the Company hereunder and thereunder
         at the Closing, and as a condition to the due and proper authorization,
         issuance, sale, and delivery of the Units to subscribers therefor in
         accordance with the terms of this Agreement has been, or prior to the
         Closing Date will have been, taken.

                  (iv) Except as contemplated by this Agreement, or as described
         in the Exchange Act Documents or the PPM (as defined in the
         Subscription Agreements), (a) there is no commitment by the Company to
         issue any shares of capital stock, subscriptions, warrants, options,
         convertible securities, or other similar rights to purchase or receive
         Company securities or to distribute to the holders of any of its equity
         securities any evidence of indebtedness, cash, or other assets, (b) the
         Company is under no obligation (contingent or otherwise) to purchase,
         redeem, or otherwise acquire any of its equity or debt securities or
         any interest therein, and (c) to the Company's knowledge there are no
         voting trusts or similar agreements, shareholders' agreements, pledge
         agreements, buy-sell agreements, rights of first refusal, preemptive
         rights, or proxies relating to any securities of the Company. Except as
         set forth in the Exchange Act Documents or filings with the Commission
         made by third parties pursuant to Schedule 13D or 13G or Form 3 or 4,
         and to the knowledge of the Company, no person holds of record or
         beneficially, 5% or more of the outstanding shares of the capital stock
         of the Company. All outstanding securities of the Company were issued
         in compliance with applicable federal and state securities laws.

                  (v) The Company is not in violation of its certificate of
         incorporation or by-laws, or in default, or with the giving of notice
         or lapse of time or both, would be in default, in the performance of
         any material obligation, agreement, or condition contained in any
         lease, license, material contract, indenture, or loan agreement or in
         any bond, debenture, note, or any other evidence of indebtedness,
         except for such defaults as would not have a Material Adverse Effect.
         The execution, delivery, and performance of this Agreement and the
         Related Agreements, the incurrence of the obligations herein, the
         issuance, sale, and delivery of the Units, and the consummation of the
         transactions contemplated herein, have been duly authorized by all
         requisite corporate action on the part of the Company and (a) do not
         and will not conflict with the Company's certificate of incorporation
         or by-laws, (b) do not and will not, with or without the passage of
         time or the giving of notice, result in the breach of, or constitute a
         default, cause the acceleration of performance, or require any consent
         under, or result in the creation of any lien, charge or encumbrance
         upon any property assets of the Company pursuant to, any material loan
         agreement, mortgage, deed of trust, indenture, or other instrument or
         agreement to which the Company is a party or by which the Company or
         its properties are bound, except such consents as have been obtained as
         of the date hereof or to the extent that the same have been, or prior
         to the Closing Date will be, waived or cured, and as may be required in
         connection with having securities listed on the NASD OTC Bulletin
         Board, that the Company undertakes to obtain as promptly as
         practicable, or (c) do not and will not result in the violation of any
         law, statute, order, rule, administrative regulation, or decree of any
         court, or governmental agency or body having jurisdiction over the
         Company or its properties.

                  (vi) Except as disclosed in the Exchange Act Documents, there
         are no preemptive rights or other rights to subscribe for or to
         purchase, or any restriction upon the voting or transfer of, the Units
         pursuant to the Company's certificate of incorporation, by-laws, or any
         agreement or other instrument to which the Company is a party. The
         issuance of the Units is not subject to any preemptive right of any
         shareholder of the Company or to any right of first refusal or other
         right in favor of any person.

                  (vii) This Agreement has been duly executed and delivered by
         or on behalf of the Company and constitutes a legal, valid, and binding
         obligation of the Company enforceable in accordance with its terms,
         except to the extent that its enforceability is limited by (a)
         applicable bankruptcy, insolvency, reorganization, moratorium, or other
         laws of general application relating to or affecting the enforcement of
         creditors' rights generally, and (b) laws relating to the availability
         of specific performance, injunctive relief, or other equitable remedies
         and except as enforceability of the indemnity and contribution
         provisions contained in Section 7 may be limited by applicable law or
         principles of public policy.

                  (viii) The Escrow Agreement has been duly executed and
         delivered by or on behalf of the Company and constitutes a legal,
         valid, and binding obligation of the Company enforceable in accordance
         with its terms, except as such enforceability may be limited by (a)
         applicable bankruptcy, insolvency, reorganization, moratorium, or other
         laws of general application relating to or affecting enforcement of
         creditors' rights generally and (b) laws relating to the availability
         of specific performance, injunctive relief, or other equitable
         remedies.

                  (ix) Except as would not have a Material Adverse Effect, the
         Company has filed, or caused to be filed, on a timely basis, all tax
         returns (including payroll, unemployment, and other taxes related to
         its employees and independent contractors) required to be filed with
         any Governmental Body and has paid or caused to be paid all taxes,
         levies, assessments, tariffs, duties or other fees imposed, assessed,
         or collected by any federal, state, municipal, or other governmental
         department, commission, board, bureau, agency, authority or
         instrumentality, domestic or foreign (each, a "Governmental Body"),
         that have become due and payable pursuant to those tax returns or
         otherwise except taxes being disputed by the Company in good faith or
         with respect to which the Company has set aside sufficient reserves and
         that are not delinquent. No deficiency assessment with respect to or
         proposed adjustment of any of the Company's Federal, state, municipal,
         or local tax returns has occurred or is threatened. There has been no
         tax lien imposed by any Governmental Body outstanding against the
         Company's assets or properties, except the lien for current taxes not
         yet due. The charges, accruals, and reserves on the books of the
         Company with respect to taxes for all fiscal periods are adequate, in
         the opinion of the Company, and the Company does not know of any actual
         or proposed tax assessment for any fiscal period or of any basis
         therefor against which adequate reserves have not been set up. The
         Company has not been advised that any Federal income tax return of the
         Company has been, or will be, examined or audited by the Internal
         Revenue Service.

                  (x) The Common Stock is registered pursuant to Section 12(b)
         of the Securities Exchange Act of 1934, amended (the "Exchange Act")
         and is quoted with the symbol "SIRC.OB" on the NASD OTC Bulletin Board.

                  (xi) The Company has not during the past six months offered or
         sold any security by or for the Company that is of the same or a
         similar class as the Units, other than offers of securities made solely
         to accredited investors or otherwise under an employee benefit plan as
         defined in Rule 405 under the Securities Act of 1933, as amended (the
         "Act"), securities issued in connection with acquisitions, or other
         securities that will not invalidate the exemption from registration
         relied on to offer and sell the Units.

                  (xii) Neither the Company nor any of its subsidiaries,
         executive officers or directors is or has been subject to any order,
         judgment, or decree of any court of competent jurisdiction temporarily,
         preliminarily, or permanently enjoining such person for failure to
         comply with Rule 503 under Regulation D.

                  (xiii) (i) The execution, delivery, and performance by the
         Company of this Agreement and the Related Agreements and (ii) the offer
         and sale of the Units require no consent of, action by or in respect
         of, or filing with, any person or Governmental Body other than those
         consents that have been obtained and filings that have been made
         pursuant to applicable state securities laws and post-sale filings
         pursuant to applicable state and federal securities laws, which the
         Company undertakes to file within the applicable time periods.

                  (xiv) There are no brokers, representatives or other persons
         who have an interest in commissions or compensation payable by the
         Company in connection with the transactions contemplated hereby other
         than you.

         3. Representations and Warranties of the Placement Agent. You represent
and warrant to, and agree with, the Company that:

                  (i) You have been duly organized and are validly existing and
         in good standing as a corporation under the laws of the State of Texas,
         with power and authority (corporate and other) to perform your
         obligations under this Agreement and the Escrow Agreement; you are a
         broker-dealer registered and in good standing under the Exchange Act
         and under the securities or Blue Sky laws of each state in which the
         Units are being offered or sold by you, and you are a member in good
         standing of the National Association of Securities Dealers, Inc.
         ("NASD"); you are in possession of and operating in compliance with all
         authorizations, licenses, permits, consents, certificates, and orders
         required for the performance of your duties under this Agreement and
         the Escrow Agreement, and your performance of your duties hereunder and
         thereunder will be in compliance with all applicable laws, including
         state securities and Blue Sky laws.

                  (ii) There are no legal or governmental proceedings pending to
         which you are a party or of which any of your properties is the subject
         or, to your knowledge, threatened, that, if determined adversely to
         you, would individually or in the aggregate materially and adversely
         affect your ability to perform your obligations under this Agreement or
         the Escrow Agreement.

                  (iii) No consent, approval, authorization or order of any
         court or governmental authority or agency is required for the
         performance by you of your obligations under this Agreement, except
         such as may be required by the NASD or under Regulation D or state
         securities or Blue Sky laws.

                  (iv) This Agreement has been duly and validly executed and
         delivered by or on behalf of you and constitutes a legal, valid, and
         binding obligation of you enforceable in accordance with its terms,
         except to the extent that its enforceability is limited by (a)
         applicable bankruptcy, insolvency, reorganization, moratorium, or other
         laws of general application relating to or affecting the enforcement of
         creditors' rights generally, and (b) laws relating to the availability
         of specific performance, injunctive relief, or other equitable remedies
         and except as enforceability of the indemnity and contribution
         provisions contained in Section 7 may be limited by applicable law or
         principles of public policy.

                  (v) The Escrow Agreement has been duly and validly executed
         and delivered by or on behalf of you and constitutes a legal, valid,
         and binding obligation of you enforceable in accordance with its terms,
         except as such enforceability may be limited by (a) applicable
         bankruptcy, insolvency, reorganization, moratorium, or other laws of
         general application relating to or affecting enforcement of creditors'
         rights generally and (b) laws relating to the availability of specific
         performance, injunctive relief, or other equitable remedies.

         4. Offering and Sale of the Units. (a) On the basis of the
representations, warranties, and covenants herein contained, but subject to the
terms and upon the conditions herein set forth, you are hereby appointed
placement agent of the Company on an exclusive basis during the term herein
specified (the "Offering Period") for the purpose of finding subscribers for the
Units on a best-efforts basis for the account of the Company at the Offering
Price through a private offering (the "Offering") to an unlimited number of
"accredited investors" (as such term is defined in Rule 501 of Regulation D)
("Accredited Investors") pursuant to and in accordance with the Act. Subject to
the performance by the Company of all its obligations to be performed hereunder,
and to the completeness and accuracy of all the representations and warranties
contained herein, you hereby accept such agency and agree on the terms and
conditions herein set forth to use your best efforts during the Offering Period
to find subscribers for Units at the Offering Price. Your agency hereunder,
which is terminable as provided in Section 11, shall terminate at 11:59 p.m.,
New York time, on January 13, 2006; provided, however, that such termination
date (the "Termination Date") may be extended by mutual written agreement of the
parties until February 28, 2006.

         (b) Each Investor desiring to purchase Units will be required to: (i)
complete, execute, and deliver to you an executed copy of (a) a Subscription
Agreement between such Investor and the Company, and (b) an Investor
Questionnaire, in the form attached as Exhibit D hereto, and (ii) deliver to the
Escrow Agent payment for such subscription in the form of a check payable to the
order of "SiriCOMM, Inc. - Escrow Account" or a wire transfer of immediately
available funds in the amount that such Investor desires to purchase as provided
in the Escrow Agreement or as otherwise directed by you. Any payment you receive
that does not conform to this requirement will be returned to an Investor by the
end of the next business day following receipt. In the event funds are received
by you, you shall hold all such Subscription Agreements and Investor
Questionnaires for safekeeping and immediately forward all funds delivered to
you to the Escrow Agent. The Escrow Agent, upon receipt of such funds, will hold
the funds in an escrow account pursuant to the Escrow Agreement. You shall
promptly forward each executed Subscription Agreement received to the Company
for acceptance or rejection together with a schedule setting forth the name and
address of each subscriber and the amount received from each subscriber. The
Company shall notify you of such acceptance or rejection within ten days of
receipt of a Subscription Agreement.

         (c) In the event that acceptable subscriptions for $2,300,000 in Units
at the Offering Price (the "Minimum Investment") shall not have been received
and accepted by the Company by the Termination Date, all funds received from
subscribers (if any) shall be returned in full, and your agency and this
Agreement shall terminate without obligation on your part or on the part of the
Company.

         (d) If, by the Termination Date or such earlier time as may be agreed
upon by you and the Company, you have received subscriptions for the Minimum
Investment and such subscriptions have been accepted by the Company (in its sole
discretion) and the other conditions to Closing the Offering of Units have been
satisfied, you shall promptly notify the Company in writing of the aggregate
amount of Units for which you have received subscriptions (the "Notice Date").
Payment of the purchase price for the Units for which you have found
subscribers, and delivery, with respect to each subscriber for Units, of a copy
of a Subscription Agreement signed by such subscriber (the "Closing"), shall
then be made at such place and time as shall be agreed upon between you and the
Company, no later than the fifth full business day after the Notice Date (the
"Closing Date").

         (e) As compensation for your services, the Company shall pay you a cash
commission of 5% of the purchase price of each Unit purchased at the Closing and
an advisory fee equal to 2% of the purchase price of each Unit purchased at the
Closing with respect to subscriptions received by you as to which the payments
and deliveries provided for in this Section 4 are made at the Closing Date. Such
commission and advisory fee shall be paid to you on the Closing Date by bank
wire transfer payable in immediately available funds. In addition, the Company
agrees to reimburse you for your reasonable expenses in accordance with Section
6.

         (f) Neither you, the Company, nor any Additional Agent (as hereinafter
defined) shall, directly or indirectly, pay or award any finder's fees,
commissions or other compensation to any person engaged by a potential investor
for investment advice as an inducement to such advisor to advise the purchase of
the Units; provided, however, that normal sales commissions payable to a
registered broker-dealer or other properly licensed person for selling the Units
shall not be prohibited hereby.

         (g) You will prepare and file such statements and reports as are or may
be required to enable the Units to be qualified for sale under the securities
laws of such jurisdictions as you may designate.

         (h) As additional compensation, the Company will issue to you on the
Closing Date a Common Stock purchase warrant (the "Placement Agent Warrant") in
substantially the form attached hereto as Exhibit E granting you the right to
purchase from the Company for a period commencing on the Closing Date and ending
five years after the Closing Date, 233,755 shares of Common Stock at a per share
purchase price equal to the Offering Price.

         (i) In connection with the Offering you will, to the extent within your
control, conduct the Offering in accordance with the applicable provisions of
the Act and Regulation D so as to preserve for the Company the exemption
provided by Rule 506 of Regulation D. You agree not to offer or sell the Units
by means of (a) any means of general solicitation, including any advertisement,
article, notice, or other communication published in any newspaper, magazine, or
similar media or broadcast over television or radio or (b) any seminar or
meeting, whose attendees have been invited by any general solicitation or
general advertising. Prior to the sale of any of the Units, you will have
reasonable grounds to believe, and in fact believe, that each subscriber for
Units is an Accredited Investor. You agree not to disclose any material
nonpublic information regarding the Company to any subscriber except as such
disclosure may be permitted pursuant to Regulation FD and is agreed to in
advance by the Company.

         (j) In connection with the performance of your obligations under this
Agreement, you may engage, for the account of the Company, the services of one
or more broker-dealers ("Additional Agents"), who are members of the NASD and
who are acceptable to the Company, and, as compensation for their services,
shall pay to such Additional Agents an amount to be negotiated between you and
such Additional Agents. Such amount will be paid to the Additional Agents by you
only out of the commissions and fees received by you in respect of sales of
Units as described in paragraph (e) of this Section 4, and the Company shall
have no obligation to any Additional Agents respecting any such payment. The
arrangements, if any, between the Company, you, and any Additional Agent shall
be set forth in an Additional Agent Agreement ("Additional Agent Agreement"),
which shall provide, among other things, that such Additional Agent shall be
deemed to have agreed to the matters set forth herein as if the Additional Agent
were a signatory hereof. Nothing contained in this Agreement or in the
Additional Agent Agreement shall be deemed to constitute the Additional Agents,
if any, as your agents, and you shall not be liable to the Company in respect of
the performance by the Additional Agents, if any, of any representations,
warranties or covenants of such Additional Agents contained herein or in the
Additional Agent Agreement.

         5. Covenants and Agreements of the Company. The Company covenants and
agrees with you that:

         (a) Except as contemplated or described in this Agreement or in a
public disclosure made prior to the date hereof, it will not, prior to the
Closing Date, incur any material liability or obligation, direct or contingent,
or enter into any material transaction, in each case, other than in the ordinary
course of business. It will not, prior to the Closing Date, declare or pay any
dividend on the Common Stock or make any distribution on the Common Stock
payable to shareholders of record on a date prior to the Closing Date.

         (b) It will cooperate with you to enable the Securities to be qualified
for sale under the securities laws of such jurisdictions as you may designate,
subject to approval by the Company, and at your request will make such
applications and furnish such information as may be required of it for that
purpose; provided, however, that you and the Company shall first determine
whether an exemption from registration other than the Uniform Limited Offering
Exemption (ULOE) or a similar exemption is available in each such jurisdiction
and the Company shall not be required to qualify to do business or to file a
general consent to service of process in any such jurisdiction. It will, from
time to time, prepare and file such statements and reports as are or may be
required to continue such qualifications in effect for so long a period as you
may reasonably request for the distribution of the Securities.

         (c) It will make available to you and each purchaser of Units at a
reasonable time prior to the Closing Date the opportunity to ask questions and
receive answers concerning the terms and conditions of the Offering and to
obtain any additional information that the Company possesses or can acquire
without unreasonable effort or expense that is necessary to verify the accuracy
of any information in the Exchange Act Documents or otherwise furnished by the
Company to you or any purchaser of Units; provided, however, that the Company
shall not be required to disclose any material nonpublic information to any
purchaser of Units.

         (d) It will file all reports required by Regulation D with regard to
sales of the Securities and use of the proceeds therefrom; provided, however,
that you provide all relevant information to the Company in writing as to
purchasers of the Securities required for such filings.

         (e) It will not offer or sell any securities of the Company that are of
the same or a similar class as the Units during the Offering Period or for a
period of six months after the Closing Date, other than those offers or sales of
securities under an employee benefit plan as defined in Rule 405 under the Act,
in connection with options, warrants, or convertible securities outstanding as
of the Closing Date, or in connection with an acquisition of assets or another
business by the Company if such offering will be integrated with the Offering of
the Units pursuant to this Agreement for purposes of the exemptions under
Regulation D, so as to invalidate the exemption from registration relied on to
offer and sell the Units.

         (f) For a period of at least 18 months following the Closing Date, the
Company will maintain the registration of its Common Stock under Section 12 of
the Exchange Act so long as the Exchange Act requires it to be so registered,
will comply in all respects with its reporting and filing obligations under the
Exchange Act, and will not take any action or file any document (whether or not
permitted by the Exchange Act or the rules thereunder) to terminate or suspend
such registration or to terminate or suspend its reporting and filing
obligations under said Act unless required to do so by the Exchange Act.

         (g) For a period of at least 18 months following the Closing Date, the
Company will use its commercially reasonable best efforts (i) to timely file all
reports required to be filed by the Company after the date hereof under the
Securities Act and the Exchange Act (including the reports pursuant to Section
13(a) or 15(d) of the Exchange Act referred to in subparagraph (c)(1) of Rule
144) and the rules and regulations adopted by the Commission thereunder), (ii)
if the Company is not required to file reports pursuant to such sections, it
will prepare and furnish to the purchasers of Units and make publicly available
in accordance with Rule 144(c) such information as is required for the
purchasers to sell the Securities under Rule 144, and (iii) to take such further
action as any holder of Units may reasonably request, all to the extent required
from time to time to enable the purchasers to sell Securities without
registration under the Securities Act within the limitation of the exemptions
provided by Rule 144, including causing its attorneys to issue and deliver any
appropriate legal opinion required to permit a purchaser to sell Securities
under Rule 144 upon receipt of appropriate documentation relating to such sale.

         (h) No later than the fourth trading day following the Closing Date,
the Company shall file a Current Report on Form 8-K disclosing the consummation
of the transactions contemplated by this Agreement and attaching copies of the
related agreements, and disclosing all material non-public information that has
been communicated to the Investors by or on behalf of the Company in connection
with the transactions contemplated by this Agreement and the Related Agreements.
In addition, the Company shall make such other filings and notices in the manner
and time required by the Securities and Exchange Commission in connection with
the consummation of the transactions contemplated by this Agreement and the
Related Agreements.

         6. Payment of Expenses. If this Agreement becomes effective and the
transactions contemplated by this Agreement are consummated, the Company will
pay (a) all reasonable expenses incident to the performance of the obligations
of the Company under this Agreement and (b) all of your reasonable out-of-pocket
expenses (including fees and disbursements of your counsel, travel, and related
expenses incurred in connection with this Agreement and the Offering) incurred
in connection with this Agreement, preparing to market, and marketing the Units,
provided, however, any single item (other than legal expenses) in excess of
$2,000 shall require the prior approval of the Company.

         7. Indemnification and Contribution. (a) The Company agrees to
indemnify and hold harmless you, each Additional Agent, and each person, if any,
who controls you or such Additional Agent within the meaning of the Act, against
any losses, claims, damages, liabilities, or expenses (including, unless the
Company elects to assume the defense as hereinafter provided, the reasonable
cost of investigating and defending against any claims therefor and counsel fees
incurred in connection therewith), joint or several, that (1) are based on the
ground or alleged ground that any information furnished to you by the Company or
its agents and furnished by you to purchasers of the Units includes or allegedly
includes an untrue statement of material fact or omits to state a material fact
necessary to make the statements therein, in light of the circumstances under
which they were made, not misleading, or (2) arise out of the Company's breach
of a representation or warranty or covenant or agreement contained in this
Agreement; provided, however, that in no case is the Company to be liable with
respect to any claims made against you, such Additional Agent, or any such
controlling person unless you, such Additional Agent, or such controlling person
shall have notified the Company in writing within a reasonable time after the
summons or other first legal process giving information of the nature of the
claim shall have been served upon you or such controlling person, but failure to
notify the Company of any such claim shall not relieve it from any liability
that it may have to you, such Additional Agent, or such controlling person
otherwise than on account of the indemnity agreement contained in this
paragraph. The Company will be entitled to participate at its own expense in the
defense, or if it so elects, to assume the defense of any suit brought to
enforce any such liability, but, if the Company elects to assume the defense,
such defense shall be conducted by counsel chosen by it and reasonably
acceptable to you. In the event the Company elects to assume the defense of any
such suit and retain such counsel, you, such Additional Agent, or such
controlling person or persons, defendant or defendants in the suit, may retain
additional counsel but shall bear the fees and expenses of such counsel unless
(i) the Company shall have specifically authorized the retaining of such counsel
or (ii) the parties to such suit include you, such Additional Agent, or such
controlling person or persons, and the Company and you, such Additional Agent,
or such controlling person or persons have been advised by counsel that one or
more material legal defenses may be available to you, such Additional Agent, or
them that may not be available to the Company in which case the Company shall
not be entitled to assume the defense of such suit notwithstanding its
obligation to bear the reasonable fees and expenses of such counsel. In no event
shall the Company be liable for the fees and expenses of more than one counsel
for all indemnified parties in connection with any one action or separate but
similar or related actions in the same jurisdiction arising out of the same
general allegations or circumstances. The Company shall not be required to
indemnify any person for any settlement of any such claim effected without the
Company's consent, which shall not be unreasonably withheld. The Company shall
not, without your consent, consent to the entry of any judgment or enter into
any settlement that does not include as an unconditional term thereof, the
giving by the claimant or plaintiff to such indemnified party of a release from
all liability in respect of such claim or litigation. This indemnification
obligation will be in addition to any primary liability that the Company might
otherwise have.

         (b) You and each Additional Agent agree to indemnify and hold harmless
the Company, each of the Company's officers, directors, and each other person,
if any, who controls the Company within the meaning of the Act, against any
losses, claims, damages, liabilities, or expenses (including, unless you or such
Additional Agent elect to assume the defense, the reasonable cost of
investigating and defending against any claims therefor and counsel fees
incurred in connection therewith), joint or several, that (i) arise out of any
acts or omissions by you or any Additional Agent, or any purchaser of Units that
cause the offering to involve a public offering under the Act or your failure to
be properly licensed to sell the Units or (ii) arise out of your breach of a
representation or warranty or covenant or agreement contained in this Agreement;
provided, however, that in no case are you or any Additional Agent to be liable
with respect to any claims made against the Company or any such person against
whom the action is brought unless the Company or such person shall have notified
you or such Additional Agent in writing within a reasonable time after the
summons or other first legal process giving information of the nature of the
claim shall have been served upon the Company or such person, but failure to
notify you or such Additional Agent of such claim shall not relieve you or such
Additional Agent from any liability that you or such Additional Agent may have
to the Company or such person otherwise than on account of the indemnity
agreement contained in this paragraph. You or such Additional Agent shall be
entitled to participate at each of their expense in the defense, or if you or
such Additional Agent so elect, to assume the defense of any suit brought to
enforce any such liability, but, if you or such Additional Agent elect to assume
the defense, counsel chosen by you or such Additional Agent and reasonably
acceptable to the Company shall conduct such defense. In the event that you or
such Additional Agent elect to assume the defense of any such suit and retain
such counsel, the Company, said officers and directors and any person or
persons, defendant or defendants in the suit, may retain additional counsel but
shall bear the fees and expenses of such counsel unless (i) you shall have
specifically authorized the retaining of such counsel or (ii) the parties to
such suit include you, such Additional Agent, or such controlling person or
persons, and the Company and you, such Additional Agent, or such controlling
person or persons have been advised by counsel that one or more material legal
defenses may be available to the Company that may not be available to you or
them in which case you shall not be entitled to assume the defense of such suit
notwithstanding its obligation to bear the reasonable fees and expenses of such
counsel. You or such Additional Agent shall not be liable to indemnify any
person for any settlement of any such claim effected without your or such
Additional Agent's consent which consent shall not be unreasonably withheld.
This indemnification obligation will be in addition to any primary liability
that you or any Additional Agent might otherwise have.

         (c) If the indemnification provided for in this Section 7 is
unavailable, then each indemnifying party shall contribute to the amount paid or
payable by such indemnified party as a result of such losses, claims, damages,
liabilities or expenses (or actions in respect thereof) in such proportion as is
appropriate to reflect not only the relative benefits received by the Company on
one hand and you and the Additional Agents, if any, on the other from the
offering, but also the relative fault of the Company on the one hand and you and
the Additional Agents, if any, on the other in connection with the statements or
omissions that resulted in such losses, claims, damages, liabilities, or
expenses (or actions in respect thereof), as well as any other relevant
equitable considerations. The relative benefits received by the Company on the
one hand and you and the Additional Agents, if any, on the other, shall be
deemed to be in the same proportion as the total net proceeds from the Offering
(before deducting expenses) received by the Company, bear to the total selling
commissions and fees received by you. The relative fault shall be determined by
reference to, among other things, whether the untrue or alleged untrue statement
of a material fact or the omission or alleged omission to state a material fact
relates to information supplied by the Company, you, or an Additional Agent, the
party's relative intent, knowledge, access to information and opportunity to
correct or prevent such statement or omission, and whether a party breached a
representation or warranty or covenant or agreement contained in this Agreement.
The Company and you agree that it would not be just and equitable if
contribution were determined by pro rata allocation or by any other method of
allocation that does not take account of the equitable considerations referred
to above. The amount paid or payable by an indemnified party as a result of the
losses, claims, damages, liabilities or expenses (or actions in respect thereof)
referred to above shall be deemed to include any legal or other expenses
reasonably incurred by such indemnified party in connection with investigating
or defending any such claim. Notwithstanding the provisions of this paragraph
(c), you shall not be required to contribute any amount in excess the
commissions and fees that you receive pursuant to Section 4(d) less the amount
of any damages that you have otherwise been required to pay by reason of an
untrue or alleged untrue statement or omission or alleged omission by the
Company. No person guilty of fraudulent misrepresentation (within the meaning of
Section 11(f) of the Act) shall be entitled to contribution from any person who
was not guilty of such fraudulent misrepresentation.

         8. Survival of Indemnities, Representations, Warranties, etc. The
respective representations and warranties of you and the Company as set forth in
this Agreement or made by them respectively, pursuant to this Agreement, shall
remain in full force and effect, regardless of any investigation made by or on
behalf of you, the Company, or any of the officers or directors of the Company
or any controlling person, and shall survive delivery of and payment for the
Units.

         9. Conditions of Your Obligations. Your obligations hereunder are
subject to the accuracy in all material respects at and (except as otherwise
stated herein) as of the date hereof and at and as of the Closing Date, of the
representations and warranties made herein by the Company, to the compliance in
all material respects at and as of the Closing Date by the Company with its
covenants and agreements herein contained and other provisions hereof to be
satisfied at or prior to the Closing Date and to the following additional
conditions:

         (a) You shall not have stated in writing prior to the Closing Date to
the Company that any Exchange Act Document, or any amendment or supplement
thereto contains an untrue statement of fact that, in your opinion, is material,
or omits to state a fact that, in your opinion, is necessary to make the
statements therein, in light of the circumstances under which they were made,
not misleading.

         (b) You shall have received a certificate, dated the Closing Date, on
behalf of the Company by the Chief Executive Officer and the Chief Financial
Officer of the Company to the effect that:

                  (i) The representations and warranties of the Company in this
         Agreement are true and correct in all material respects at and as of
         the Closing Date, and the Company has complied in all material respects
         with all the agreements and satisfied in all material respects all the
         conditions on its part to be performed or satisfied at or prior to the
         Closing Date;

                  (ii) Between the date of this Agreement and the Closing Date,
         no litigation has been instituted or, to the knowledge of the Company,
         threatened against the Company of a character required to be disclosed
         in an Exchange Act Document under Item 103 of Regulation S-K that has
         not been so disclosed to you; and

                  (iii) Between the date of this Agreement and the Closing Date,
         there has not been any material adverse change in the financial
         condition, business, or results of operations of the Company.

         (c) The Company shall have entered into the Related Agreements.

         (d) You shall have received from Sommer & Schneider LLP, counsel to the
Company, an opinion, dated the Closing Date, with respect to such matters as you
may reasonably request.

         (e) You shall have received such other documentation reasonably
requested by you to effect the transactions contemplated herein.

         If any of the conditions provided for in this Section 9 shall not have
been satisfied when and as required by this Agreement, this Agreement may be
terminated by you by notifying the Company of such termination in writing at or
prior to the Closing Date, but you shall be entitled to waive any of such
conditions.

         10. Effective Date. This Agreement shall become effective at 11:00
A.M., New York time, on the date hereof (the "Effective Time").

         11. Termination. In the event of any termination of this Agreement
under this or any other provision of this Agreement, there shall be no liability
of any party to this Agreement to any other party, other than as provided in
Sections 6, 7, and 8 and this Section 11.

         This Agreement may be terminated after the Effective Time (a) by the
Company for any reason by notice to you and (b) by you by notice to the Company
(i) if at or prior to the Closing Date trading in securities on the New York
Stock Exchange, the American Stock Exchange, or the Nasdaq Stock Market
(collectively, the "Exchanges") shall have been suspended for longer than four
consecutive hours or minimum or maximum prices shall have been established on
either such exchange or stock market, or a banking moratorium shall have been
declared by New York or United States authorities (unless such suspension is
made pending completion of the sale of the Units, at which time, such suspension
will be lifted); (ii) if at or prior to the Closing Date there shall have been a
material escalation of hostilities between the United States and any foreign
country (other than Iraq), or any other material insurrection or armed conflict
involving the United States that, in your judgment, after consultation with the
Company, makes it impracticable or inadvisable to offer or sell the Units; or
(iii) if there shall be any litigation or regulatory action, pending or
threatened against or involving the Company, that, in your judgment, makes it
impracticable or inadvisable to offer or deliver the Units on the terms
contemplated by this Agreement.

         If, and only if, the Company terminates this Agreement after it becomes
effective for any reason (other than your material failure to comply with your
obligations under this Agreement or material breach of your representations and
warranties) or the Offering fails to close because of the Company's breach of
any representations or warranties contained in this Agreement or the Company's
failure to fulfill its covenants and agreements contained in this Agreement, the
Company shall pay you your actual out-of-pocket expenses incurred as provided in
Section 6.

         12. Agreement Concerning Disclosure of Information. You agree to treat
confidentially any material nonpublic information that is furnished to you (or
to parties acting on your behalf) by or on behalf of the Company (the
"Information"). You agree that you will use the Information only for the
purposes related to a determination of your willingness to act as exclusive
selling agent pursuant to this Agreement, and that the Information will be kept
confidential by you and your partners, members, managers, officers, directors,
employees, agents, and other affiliates (collectively, the "Affiliates"), and
your attorneys and accountants (collectively, the "Professionals"), and that
you, such Affiliates, or Professionals will not disclose the Information to any
investor or other person; provided, however, that the Information may be
disclosed to (a) Affiliates and Professionals who need to know such Information
for the purpose of evaluating or providing services in connection with the your
and your clients' investment in the Company; provided, however, such persons are
advised of and agree to maintain the confidential nature of such information,
(b) to any federal or state regulatory agency and their employees, agents, and
attorneys (collectively, "Regulators") for the purpose of making any filings
with Regulators if disclosure of such Information is required by law (provided,
however, that you advise the Company in writing of the Information to be so
disclosed prior to such filing), (c) any other person to which the Company
consents in writing prior to any such disclosure.

         In the event that you are requested or required (by oral questions,
documents, subpoena, civil investigation, demand, interrogatories, request for
information, or other similar process) to disclose to any person or entity any
information supplied to you, your Affiliates, or your Professionals in the
course of their dealings with the Company or their respective representatives,
you agree that you will provide the Company with prompt notice of such
request(s) within a reasonable time prior to such disclosure so that the Company
may seek an appropriate protective order and/or waiver of compliance with the
provisions of this Agreement. It is further agreed that, if a protective order
is not obtained, or a waiver is not granted hereunder, and you are nonetheless,
in the written opinion of counsel, compelled to disclose information concerning
the Company to any tribunal or else stand liable for contempt or suffer the
censure or penalty, you may disclose such information to such tribunal without
liability hereunder. Prior to making such disclosure, you shall deliver a
written opinion of your counsel to the Company's counsel that disclosure is
compelled by law. You will exercise your best efforts to obtain a protective
order or other reliable assurance that confidential treatment will be accorded
the Information.

         13. Notices. All notices or other communications that are required or
permitted under this Agreement shall be in writing and sufficient if delivered
by hand, by facsimile transmission, by registered or certified mail, postage
pre-paid, by electronic mail, or by courier or overnight carrier, to the persons
at the addresses set forth below (or at such other address as may be provided
hereunder), and shall be deemed to have been delivered as of the date so
delivered:

    If to the Company:  SiriCOMM, Inc.
                        2900 Davis Boulevard, Suite 130
                        Joplin, Missouri  64804
                        Attention: Henry P. Hoffman, Chairman, President and CEO
                        Facsimile:  (417) 626-9971
                        e-mail: hank.hoffman@siricomm.com

                        With a copy to:
                        Sommer & Schneider LLP
                        595 Stewart Avenue, Suite 710
                        Garden City, New York  11530
                        Attention: Joel C. Schneider, Esq.
                        Facsimile:  (516) 228-8211
                        e-mail: jschneider@ssllplaw.net

    If to you:          Sanders Morris Harris Inc.
                        527 Madison Avenue, 7th Floor
                        New York, New York 10022
                        Attention:  Stephen Bonebrake, Managing Director
                        Facsimile:  (212) 419-3956
                        e-mail: stephen.bonebrake@smhgroup.com

                        With a copy to:
                        Day, Berry & Howard LLP
                        One East Putnam Avenue
                        Greenwich, CT 06830
                        Attention: R. Scott Beach, Esq.
                        Facsimile:  (203) 862-7801
                        e-mail: rsbeach@dbh.com

or at such other address as any party shall have furnished to the other parties
in writing.

         14. Successors. This Agreement shall inure to the benefit of and be
binding upon you, and Additional Agents, the Company, and their respective
successors and legal representatives, except that neither the Company nor you
may assign or transfer any of its or your rights or obligations under this
Agreement without the prior written consent of the other. Nothing expressed or
mentioned in this Agreement is intended or shall be construed to give any person
other than the persons mentioned in the preceding sentence any legal or
equitable right, remedy or claim under or in respect of this Agreement, or any
provisions herein contained, this Agreement and all conditions and provisions
hereof being intended to be and being for the sole and exclusive benefit of such
persons and for the benefit of no other person; except that the representations,
warranties, covenants, agreements and indemnities of the Company contained in
this Agreement shall also be for the benefit of the person or persons, if any,
who control you or any Additional agents within the meaning of Section 15 of the
Act, and your and any Additional Agent's indemnities shall also be for the
benefit of each officer and director of the Company and the person or persons,
if any, who control the Company within the meaning of Section 15 of the Act.

         15. Applicable Law. This Agreement shall be governed by and construed
in accordance with the laws of the State of New York. Any judicial proceeding
brought against either of the parties to this agreement or any dispute arising
out of this Agreement or any matter related hereto shall be brought in the
courts of the State of New York, New York County or in the United States
District Court for the Southern District of New York and, by its execution and
delivery of this agreement, each party to this Agreement accepts the exclusive
jurisdiction of such courts. The foregoing consent to jurisdiction shall not be
deemed to confer rights on any person other than the parties to this Agreement.
The prevailing party in any such litigation shall be entitled to receive from
the losing party or parties all costs and expenses, including reasonable
attorney fees, incurred by the prevailing party.

                       [Signatures on the following page]

<PAGE>

         If the foregoing correctly sets forth our understanding please indicate
your acceptance thereof in the space provided below for that purpose, whereupon
this letter and your acceptance shall constitute a binding agreement between us.

                                                Very truly yours,

                                                SIRICOMM, INC.

                                                 By:    /s/ Henry P. Hoffman
                                                    --------------------------
                                                 Name:   Henry P. Hoffman
                                                      ------------------------
                                                 Title:     President / CEO
                                                       -----------------------

Accepted and delivered in New York, New York as of the date first above written.

SANDERS MORRIS HARRIS INC.

By:   /s/ Stephen W. Bonebrake
   -----------------------------
Name:  Stephen W. Bonebrake
     ---------------------------
Title:  Managing Director
      --------------------------

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00097-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00097-of-00352.parquet"}]]